PROGRAM CHAIR
Jonathan A. Bernstein, MD
Professor of Clinical Medicine
University of Cincinnati
Department of Internal Medicine
Division of Rheumatology, Allergy and Immunology
Cincinnati, OH
PROGRAM DESCRIPTION
This enduring activity has been designed to meet the educational needs of health care providers who diagnose, treat, and/or manage patients with chronic spontaneous urticaria (CSU). We aim to help healthcare practitioners to better understand the etiopathogenesis of CSU, enabling prompt diagnosis and treatment initiation. The program will present clinical trial data on emerging biologics targeting the underlying pathophysiology of CSU, and will identify strategies to individualize patient management to best achieve treatment goals.
TARGET AUDIENCE
This program will meet the educational needs of primary care physicians, dermatologists, allergists/immunologists, nurse practitioners, physician assistants, and other health care providers who diagnose, treat, and/or manage patients with CSU.
LEARNING OBJECTIVES
- Describe etiopathogenesis of CSU for prompt diagnosis and treatment initiation
- Discuss clinical trial data on the efficacy and safety of emerging biologics that target the underlying pathophysiology of CSU
- Identify strategies for effective individualized patient management including communication, shared decision-making, and achieving treatment goals
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Faculty Member | Disclosures |
Jonathan A. Bernstein, MD | Consulting Fees: Novartis, Genentech, TEVA, Sanofi/Regeneron, AstraZeneca, Allakos, and Celldex Therapeutics. Contracted Research: Novartis, Genentech, TEVA, Sanofi/Regeneron, AstraZeneca, Allakos, and Celldex Therapeutics. Unlabeled/Unapproved Drugs: Novartis (remibrutinib, ligelizumab), Genentech, TEVA, Sanofi/Regeneron (dupilumab), AstraZeneca (benralizumab), Allakos (lirentelimab), and Celldex Therapeutics. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Lisa Kuhns, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation & Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Melissa Johnson, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Amanda Jenkins, Associate Program Manager for Med Learning Group, has nothing to disclose.
- Millena Debrito, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: November 30, 2023
EXPIRATION DATE: November 30, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.